Veklury and Prednisolone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Veklury and Prednisolone. Common interactions include bradypnoea among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people who take Veklury and Prednisolone have. It is created by eHealthMe based on reports of 21 people who take Veklury and Prednisolone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

21 people who take Veklury and Prednisolone together, and have interactions are studied.

What is Veklury?

Veklury has active ingredients of remdesivir. eHealthMe is studying from 1,574 Veklury users for its effectiveness, alternative drugs and more.

What is Prednisolone?

Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 182,055 Prednisolone users for its effectiveness, alternative drugs and more.

Number of Veklury and Prednisolone reports submitted per year:

Common Veklury and Prednisolone drug interactions by gender *:

female:

Bradypnoea
Hepatic enzyme increased
Oxygen saturation decreased
Pruritus
Renal impairment
Respiratory arrest
Dyspnoea
Neuropathy peripheral

male:

Drug ineffective
Respiratory disorder
Vomiting
Infection reactivation
Interstitial lung disease
Hyperkalaemia
Pulmonary tuberculosis
Renal impairment
Acute myeloid leukaemia recurrent
Altered state of consciousness

Common Veklury and Prednisolone drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Oxygen saturation decreased
Pyrexia

40-49:

n/a

50-59:

Drug ineffective
Neuropathy peripheral

60+:

Drug ineffective
Renal impairment
Vomiting
Infection reactivation
Interstitial lung disease
Bradypnoea
Hyperkalaemia
Oxygen saturation decreased
Pulmonary tuberculosis
Respiratory arrest

Common conditions people have *:

High Blood Pressure: 4 people, 19.05%
Osteochondritis (a painful type of osteochondritis where the cartilage or bone in a joint is inflamed): 3 people, 14.29%
Osgood-Schlatter Disease (an overuse injury that occurs in the knee area of growing adolescents. it is caused by inflammation of the tendon below the kneecap): 3 people, 14.29%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 14.29%
Gastritis (inflammation of stomach): 3 people, 14.29%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 14.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 14.29%
Systemic Candida (whole body fungal infection): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Veklury and Prednisolone?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Abdullah, D., Mohamed, A. M. F. S., & Liew, A. K. C., "Dentine hypersensitivity-like tooth pain associated with the use of high-dose steroid therapy", Journal of conservative dentistry: JCD, 2018 Jan .